載入中
NYSETechnologyInformation Technology Services
最新資料
US$1.61
−US$0.02 · -1.23%
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
前收盤價
US$1.61
−US$0.02 · -1.23%
盤中時間採用ET。市場資料可能有所延遲。
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
日內區間
目前US$1.61
52週區間
目前US$1.61
盤中時間採用ET。市場資料可能有所延遲。
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
日內區間
目前US$1.61
52週區間
目前US$1.61
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 24.55億 USD | 25.57億 USD | 26.29億 USD | 26.6億 USD | 18.77億 USD |
| 銷貨成本 | 8.34億 USD | 8.69億 USD | 9.06億 USD | 9.54億 USD | 6.26億 USD |
| 毛利 | 16.22億 USD | 16.88億 USD | 17.22億 USD | 17.06億 USD | 12.51億 USD |
| 銷售、一般及管理費用 | 7.09億 USD | 7.28億 USD | 7.4億 USD | 7.3億 USD | 6.43億 USD |
| 營業費用 | 15.5億 USD | 19.63億 USD | 24.57億 USD | 56.31億 USD | 13.38億 USD |
| 利息支出 | 2.65億 USD | 2.83億 USD | 2.94億 USD | 2.7億 USD | 2.53億 USD |
| 折舊和攤銷 | 7.57億 USD | 7.27億 USD | 7.08億 USD | 7.11億 USD | 5.38億 USD |
| 營業利益 | 7150萬 USD | −2.76億 USD | −7.35億 USD | −39.26億 USD | −8700萬 USD |
| 淨利 | −2.01億 USD | −6.37億 USD | −9.11億 USD | −39.6億 USD | −2.71億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$2.00
上漲空間 24.22%報告持有此股票曝險的交易所交易基金。
Avantis U.S. Small Cap Value ETFAVUV2593.13萬0.08%308.51億 USD0.25%US$119.64-0.41%
iShares Russell 2000 ETFIWM1519.33萬0.02%787.4億 USD0.19%US$278.94+0.49%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1206.06萬0.04%268.09億 USD0.33%US$37.95-0.39%
Vanguard Extended Market ETFVXF1021.04萬0.01%954億 USD0.05%US$235+0.80%
Dimensional - US Targeted Value ETFDFAT423.33萬0.01%301.22億 USD0.33%US$67.27-0.43%
Vanguard Russell 2000 ETFVTWO412.28萬0.02%180億 USD0.06%US$112.66+0.50%
Schwab Fundamental U.S. Small Company Index ETFFNDA386.91萬0.04%87.82億 USD0.25%US$35.62+0.17%
EA Bridgeway Omni Small-Cap Value ETFBSVO384萬0.16%23.91億 USD0.45%US$28.37-0.64%Avantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATVanguard Russell 2000 ETFVTWOSchwab Fundamental U.S. Small Company Index ETFFNDAEA Bridgeway Omni Small-Cap Value ETFBSVOAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
